坏死松解性游走性红斑作为胰高血糖素瘤的首发表现
Necrolytic migratory erythema as the first manifestation of glucagonoma.
作者信息
Afsharfard Abolfazl, Atqiaee Khashayar, Lotfollahzadeh Saran, Alborzi Majid, Derakhshanfar Amir
机构信息
Department of General Surgery, Institute of Surgery, Shohaday-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Shahid Chamran Highway Yaman St, Tehran 1985717443, Iran.
出版信息
Case Rep Surg. 2012;2012:974210. doi: 10.1155/2012/974210. Epub 2012 Aug 27.
Abstract
Necrolytic migratory erythma (NME) as a rare skin disorder that can affected Perineum, distal extremities, lower abdomen and face are the most commonly affected sites.It can be as a part of Glucagonoma syndrome that is defined as an association of glucagonoma with NME, hyperglucagonemia, glucose intolerance, anemia and weight loss. Here, Authors describe a woman admitted to the dermatology ward with NME which was later found to be associated with glucagonoma and multiple hepatic lesions.
摘要
坏死性游走性红斑（NME）是一种罕见的皮肤疾病，可累及会阴、四肢远端、下腹部和面部，这些部位是最常受累的部位。它可能是胰高血糖素瘤综合征的一部分，该综合征定义为胰高血糖素瘤与NME、高胰高血糖素血症、葡萄糖耐量异常、贫血和体重减轻相关联。在此，作者描述了一名因NME入住皮肤科病房的女性，后来发现其与胰高血糖素瘤和多处肝脏病变有关。
相似文献
1
Necrolytic migratory erythema as the first manifestation of glucagonoma.坏死松解性游走性红斑作为胰高血糖素瘤的首发表现
Case Rep Surg. 2012;2012:974210. doi: 10.1155/2012/974210. Epub 2012 Aug 27.
2
Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.坏死性游走性红斑作为胰腺神经内分泌肿瘤的首发表现
World J Surg Oncol. 2014 Jul 17;12:220. doi: 10.1186/1477-7819-12-220.
3
Necrolytic migratory erythema and glucagonoma rising from pancreatic head.坏死松解性游走性红斑和胰头起源的胰高血糖素瘤。
Pancreatology. 2013 Jul-Aug;13(4):455-7. doi: 10.1016/j.pan.2013.03.011. Epub 2013 Mar 30.
4
Necrolytic migratory erythema and pancreatic glucagonoma.坏死性游走性红斑与胰腺高血糖素瘤。
Biomedica. 2016 Jun 3;36(2):176-81. doi: 10.7705/biomedica.v36i3.2723.
5
Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.坏死松解性游走性红斑：一种被遗忘的副肿瘤性疾病。
J Cutan Med Surg. 2017 Nov/Dec;21(6):559-561. doi: 10.1177/1203475417719051. Epub 2017 Jun 29.
6
Necrolytic migratory erythema associated with glucagonoma syndrome: a case report.与胰高血糖素瘤综合征相关的坏死性游走性红斑：一例报告
Rev Hosp Clin Fac Med Sao Paulo. 2001 Nov-Dec;56(6):183-8. doi: 10.1590/s0041-87812001000600005.
7
Glucagonoma With Necrolytic Migratory Erythema: Metabolic Profile and Detection of Biallelic Inactivation of DAXX Gene.胰高血糖素瘤伴坏死游走性红斑：代谢特征及 DAXX 基因双等位基因失活的检测。
J Clin Endocrinol Metab. 2018 Jul 1;103(7):2417-2423. doi: 10.1210/jc.2017-02646.
8
Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.奥曲肽成功治疗转移性胰高血糖素瘤所致犬坏死性游走性红斑（浅表坏死性皮炎）
Vet Dermatol. 2010 Oct;21(5):510-6. doi: 10.1111/j.1365-3164.2009.00876.x. Epub 2010 May 24.
9
Case of delayed diagnosis of necrolytic migratory erythema.坏死性游走性红斑延迟诊断病例
Clin Case Rep. 2021 Dec 11;9(12):e05179. doi: 10.1002/ccr3.5179. eCollection 2021 Dec.
10
A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.胰高血糖素瘤综合征皮肤表现的综述：坏死性游走性红斑。
Int J Dermatol. 2018 Jun;57(6):642-645. doi: 10.1111/ijd.13947. Epub 2018 Feb 16.
引用本文的文献
1
Case report: Surgical treatment and literature review of a recurrent case of glucagonoma.病例报告：一例复发性胰高血糖素瘤的外科治疗及文献复习
Front Oncol. 2024 Aug 26;14:1437102. doi: 10.3389/fonc.2024.1437102. eCollection 2024.
2
Case of delayed diagnosis of necrolytic migratory erythema.坏死性游走性红斑延迟诊断病例
Clin Case Rep. 2021 Dec 11;9(12):e05179. doi: 10.1002/ccr3.5179. eCollection 2021 Dec.
3
Unremitting chronic skin lesions: a case of delayed diagnosis of glucagonoma.持续性慢性皮肤病变：一例胰高血糖素瘤延迟诊断病例
J Community Hosp Intern Med Perspect. 2019 Nov 1;9(5):425-429. doi: 10.1080/20009666.2019.1671574. eCollection 2019.
4
Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.坏死性游走性红斑作为胰腺神经内分泌肿瘤的首发表现
World J Surg Oncol. 2014 Jul 17;12:220. doi: 10.1186/1477-7819-12-220.
本文引用的文献
1
The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.胰高血糖素瘤综合征与坏死性游走性红斑：临床综述
Eur J Endocrinol. 2004 Nov;151(5):531-7. doi: 10.1530/eje.0.1510531.
2
Benign and malignant cutaneous tumors in the elderly.老年人的良性和恶性皮肤肿瘤。
Arch Dermatol. 1961 Feb;83:262-71. doi: 10.1001/archderm.1961.01580080092010.
3
Necrolytic migratory erythema as the only presenting sign of a glucagonoma.坏死性游走性红斑作为胰高血糖素瘤的唯一表现体征。
J Am Acad Dermatol. 2003 Aug;49(2):325-8. doi: 10.1067/s0190-9622(02)61774-8.
4
Duodenal somatostatinoma: a case report and review of 31 cases with special reference to the relationship between tumor size and metastasis.十二指肠生长抑素瘤：一例报告并对31例病例进行回顾，特别提及肿瘤大小与转移之间的关系。
Pathol Int. 2000 Feb;50(2):146-52. doi: 10.1046/j.1440-1827.2000.01016.x.
5
Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors.与恶性神经内分泌肿瘤相关的高胰高血糖素血症的临床谱
Mayo Clin Proc. 1996 Nov;71(11):1030-8. doi: 10.4065/71.11.1030.
6
Necrolytic migratory erythema with pancreatic carcinoma.伴有胰腺癌的坏死性游走性红斑
Proc R Soc Med. 1971 Dec;64(12):1197-8. doi: 10.1177/003591577106401212.
7
A glucagon-secreting alpha-cell carcinoma of the pancreas.胰腺的一种分泌胰高血糖素的α细胞癌。
N Engl J Med. 1966 Jun 23;274(25):1408-13. doi: 10.1056/NEJM196606232742503.
8
A glucagonoma syndrome.一种胰高血糖素瘤综合征。
Lancet. 1974 Jul 6;2(7871):1-5. doi: 10.1016/s0140-6736(74)91343-9.
9
Histologic variation in the skin lesions of the glucagonoma syndrome.胰高血糖素瘤综合征皮肤病变的组织学变异
Am J Surg Pathol. 1986 Jul;10(7):445-53. doi: 10.1097/00000478-198607000-00001.
10
Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.生长抑素类似物（SMS 201-995）在胰高血糖素瘤综合征中的应用。
Surgery. 1986 Dec;100(6):989-96.
Zotero 插件